WO2004022564A3 - Alternative processes for the preparation of d- (+) -morphine, and d- (+) - morphine tartrate - Google Patents

Alternative processes for the preparation of d- (+) -morphine, and d- (+) - morphine tartrate Download PDF

Info

Publication number
WO2004022564A3
WO2004022564A3 PCT/GB2003/003805 GB0303805W WO2004022564A3 WO 2004022564 A3 WO2004022564 A3 WO 2004022564A3 GB 0303805 W GB0303805 W GB 0303805W WO 2004022564 A3 WO2004022564 A3 WO 2004022564A3
Authority
WO
WIPO (PCT)
Prior art keywords
morphine
converting
under conditions
conditions effective
dihydrosinomenine
Prior art date
Application number
PCT/GB2003/003805
Other languages
French (fr)
Other versions
WO2004022564A2 (en
Inventor
John Whittall
Paul Mather
Original Assignee
Stylacats Ltd
John Whittall
Paul Mather
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stylacats Ltd, John Whittall, Paul Mather filed Critical Stylacats Ltd
Priority to AU2003263301A priority Critical patent/AU2003263301A1/en
Publication of WO2004022564A2 publication Critical patent/WO2004022564A2/en
Publication of WO2004022564A3 publication Critical patent/WO2004022564A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a process for the production of (+)-morphine from (-)-sinomenine comprising contacting (-)-sinomenine with H2/Pd/C under conditions effective for converting sinomenine to 7(S)-(+)-dihydrosinomenine or 7(R)-(+)-dihydrosinomenine or a mixture thereof; contacting the resulting 7(S)-(+)-dihydrosinomenine or 7(R)-(+)-dihydrosinomenine or a mixture thereof with polyphosphoric acid or Eatons reagent under conditions effective for converting 7(S)-(+)-dihydrosinomenine or 7(R)-(+)-dihydrosinomenine or a mixture thereof to (+)-dihydrocodeinone; contacting the resulting (+)-dihydrocodeinone either with (MeO)3CH followed by TsOH followed by NBA/MeOH under conditions effective for converting (+)-dihydrocodeinone to (+)-1,7-dibromodihydrocodeinone dimethylketal; contacting the resulting (+)-1,7-dibromodihydrocodeinone dimethylketal with t-butoxide followed by acid under conditions effective for converting (+)-1,7-dibromodihydrocodeinone dimethylketal to (+)-1-bromocodeinone; contacting the resulting (+)-1­bromocodeinone with LiAlH4 followed by BBr3 under conditions effective for converting (+)-1-bromocodeinone to (+)-morphine; or with o-iodoxybenzoic acid (IBX) and 4-methoxypyridine-N-oxide under conditions effective for converting (+)-dihydrocodeinone to (+)-codeinone; contacting the resulting (+)-codeinone with sodium borohydride followed by BBr3 under conditions effective for converting (+)-codeinone to (+)-morphine; and in either case recovering the resulting (+)-morphine as product. The invention also relates to novel compounds produced during the process.
PCT/GB2003/003805 2002-09-03 2003-09-03 Alternative processes for the preparation of d- (+) -morphine, and d- (+) - morphine tartrate WO2004022564A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003263301A AU2003263301A1 (en) 2002-09-03 2003-09-03 Alternative processes for the preparation of d- (+) -morphine, and d- (+) - morphine tartrate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0220385.9 2002-09-03
GB0220385A GB2392670A (en) 2002-09-03 2002-09-03 (+)-Morphine production

Publications (2)

Publication Number Publication Date
WO2004022564A2 WO2004022564A2 (en) 2004-03-18
WO2004022564A3 true WO2004022564A3 (en) 2004-07-01

Family

ID=9943367

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/003805 WO2004022564A2 (en) 2002-09-03 2003-09-03 Alternative processes for the preparation of d- (+) -morphine, and d- (+) - morphine tartrate

Country Status (3)

Country Link
AU (1) AU2003263301A1 (en)
GB (1) GB2392670A (en)
WO (1) WO2004022564A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2610859C (en) 2005-06-16 2013-11-12 Peter Xianqi Wang A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
EP2167505B1 (en) * 2007-07-17 2012-11-28 Mallinckrodt LLC Preparation of n-alkylated opiates by reductive amination
EP2328899B1 (en) 2008-09-16 2018-01-24 Mallinckrodt LLC Processes for the synthesis of five and six membered heterocyclic rings
WO2010065441A1 (en) * 2008-12-02 2010-06-10 Mallinckrodt Inc. Process for preparing hydrocodone using a super acid
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
EP2398807A1 (en) * 2009-02-23 2011-12-28 Mallinckrodt LLC (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
WO2010096790A1 (en) * 2009-02-23 2010-08-26 Mallinckrodt Inc. (+)-morphinananium n-oxides and processes for their production
US10363251B2 (en) 2009-07-16 2019-07-30 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
PL2453895T3 (en) * 2009-07-16 2018-10-31 Mallinckrodt Llc (+) - morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
PL2593095T3 (en) 2010-07-16 2019-12-31 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
CN104672142B (en) * 2015-02-13 2017-08-04 江苏大学 The preparation of diadactic structure Sinomenine derivate and medical usage
CN109666030B (en) * 2018-11-19 2021-04-27 兰州大学 Method for catalyzing asymmetric synthesis of codeine and morphine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025520A (en) * 1974-04-10 1977-05-24 Macfarlan Smith Limited Dehydrohalogenation of a 7-halodihydrocodeinone dialkyl ketal
WO1991002485A1 (en) * 1989-08-17 1991-03-07 Research Foundation Of The City University Of New York Microelectrodes and their use in a cathodic electrochemical current arrangement with telemetric application

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025520A (en) * 1974-04-10 1977-05-24 Macfarlan Smith Limited Dehydrohalogenation of a 7-halodihydrocodeinone dialkyl ketal
WO1991002485A1 (en) * 1989-08-17 1991-03-07 Research Foundation Of The City University Of New York Microelectrodes and their use in a cathodic electrochemical current arrangement with telemetric application

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BRODERICK, P. A.: "In Vivo Electrochemical Studies of Rat Striatal Dopamine and Serotonine Release after Morphine", LIFE SCIENCES, vol. 36, 1985, pages 2269 - 2275, XP009022736 *
GOTO, K.; YAMAMOTO, I.: "(+)-Codeine and (+)-Morphine from Sinomenine", PROC. JPN. ACAD., vol. 30, 1954, pages 769 - 773, XP009022637 *
IIJIMA, I. ET AL.: "Studies in the (+)-Morphinan Series. 4. A Markedly Improved Synthesis of (+)-Morphine.", J. ORG. CHEM., vol. 43, no. 7, 1978, pages 1462 - 1463, XP001156547 *
J .ORG. CHEM.,SUPPLEMENTAL PAGES, vol. 62, 1997, pages 1 - 13, XP002275946 *
NICOLAOU K C ET AL: "A NEW METHOD FOR THE ONE-STEP SYNTHESIS OF A,BETA-UNSATURATED CARBONYL SYSTEMS FROM SATURATED ALCOHOLS COMPOUNDS", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 122, no. 31, 9 August 2000 (2000-08-09), pages 7596 - 7597, XP000937227, ISSN: 0002-7863 *
NICOLAOU; K. C. ET AL.: "Modulation of the Reactivity Profile of IBX by Ligand Complexation ...", ANGEW. CHEM. INT. ED., vol. 41, no. 6, 15 March 2002 (2002-03-15), pages 993 - 996, XP002275169 *
STRINGER, M. ET AL.: "d-Morphine, but not l-morphine, has low micromolar affinity for the non-competitive N-methyl-D-aspartate site in rat forebrain. ...", NEUROSCIENCE LETT., vol. 295, 2000, pages 21 - 24, XP002264370 *
WHITE, J. D. ET AL.: "Asymmetric Synthesis of (+)-Morphine. The Phenanthrene Route Revisited.", J. ORG. CHEM., vol. 62, 1997, pages 5250 - 5251, XP002275168 *

Also Published As

Publication number Publication date
WO2004022564A2 (en) 2004-03-18
AU2003263301A1 (en) 2004-03-29
GB0220385D0 (en) 2002-10-09
GB2392670A (en) 2004-03-10
AU2003263301A8 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
WO2004022564A3 (en) Alternative processes for the preparation of d- (+) -morphine, and d- (+) - morphine tartrate
Stephen et al. Synthesis of brevetoxin sub-units by sequential ring-closing metathesis and hydroboration
Lakhmiri et al. Allyl ethyl carbonate/palladium (0), a new system for the one step conversion of alcohols into allyl ethers under neutral conditions
ZA200701784B (en) Preparation of opiate analgesics by reductive alkylation
EP1664061B1 (en) Process for the synthesis of morphinane compounds and intermediates thereof
WO2001040184B1 (en) Methods for the syntheses of alfentanil, sufentanil and remifentanil
Hong et al. Preparation of opium alkaloids by palladium catalyzed bis-cyclizations. Formal total synthesis of morphine
Garigipati et al. Total synthesis of (+)-actinobolin
US8106201B2 (en) Process for the synthesis of morphinane compounds and intermediates thereof
CA2067200C (en) Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
Ghimire et al. Short syntheses of the tricyclic indole alkaloids cimitrypazepine and fargesine
EP2580201B1 (en) Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
HU0001618D0 (en) Process for producing a known tetrazole derivative
JP2004520312A5 (en)
AU2009260121C1 (en) Process for the synthesis of N-demethylated morphinane compounds
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
TWI287016B (en) Process for preparing camptothecin
Frey et al. Comparison of approaches to ent-morphine via radical, cationic, and Heck-type cyclizations
Gotteland et al. Design and synthesis of new hypocholesterolemic organosilanes with antioxidant properties
Bhaskar kanth et al. Convenient method for N-debenzylation of tertiary amines
AU2003287975A1 (en) Method for the production of compounds containing palladium (0)
CN112679512A (en) Tributine intermediate and preparation method thereof
EP1270582A4 (en) Triphenylphosphine derivative, production process therefor, palladium complex thereof, and process for producing biaryl derivative
EP1640358A1 (en) Synthesis of amine stereoisomers
AU2004274038B8 (en) Process for the synthesis of morphinane compounds and intermediates thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP